This inventor holds 2 USPTO granted patents. Top assignee: International Business Machines Corporation. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Rubén Ruelas-Lepe: Innovator in Breast Cancer Detection
Introduction
Rubén Ruelas-Lepe is a notable inventor based in Zapopan, Mexico. He has made significant contributions to the field of medical technology, particularly in breast cancer detection. With a total of 2 patents to his name, Ruelas-Lepe is recognized for his innovative approaches to improving diagnostic methods.
Latest Patents
Ruelas-Lepe's latest patents focus on a hybrid detection model for breast cancer. This system is designed to identify regions of interest on received mammograms. Each pixel of the image may have a specific level of grey, which is crucial for analysis. The system applies both morphological and entropy filters to the identified region. Based on these filters, a hybrid result is generated, which is the average of the two filters. Finally, the system segments the region of interest using a selected clustering algorithm, enhancing the accuracy of breast cancer detection.
Career Highlights
Rubén Ruelas-Lepe is currently employed at International Business Machines Corporation, commonly known as IBM. His work at IBM allows him to collaborate with leading experts in the field and contribute to groundbreaking research and development.
Collaborations
Some of Ruelas-Lepe's notable coworkers include Juan Manuel A Vega and Ramón Oswaldo G Medina. Their collaboration fosters an environment of innovation and shared expertise, further advancing their collective work in medical technology.
Conclusion
Rubén Ruelas-Lepe is a distinguished inventor whose work in breast cancer detection exemplifies the impact of innovation in healthcare. His contributions are paving the way for more effective diagnostic tools, ultimately benefiting patients and the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
